Cellular and genetic therapies drive a ‘new paradigm’ for logistics
Very good article highlighting the challenges of moving the new cell therapies and industry's response. Savsu, Bruce McCormick, and our DV-10 featured in the article along with folks from BioLife, TrakCel, Fisher BioServices, and Cryoport. Thanks to Pharmaceutical Commerce for presenting such a good article and including us.
"While all of this is generating high enthusiasm in R&D circles, logistics service providers are scrambling to revise their processes to meet the new demands of these therapies. A “new paradigm” is evolving, in the words of Bruce McCormick, President of Savsu..."